Cervical and Uterine Cancer: Novel Advances in Personalized Medicine in 2024
By: Kathleen N. Moore, MD, MS
Immunotherapy in Oncology Session II
By: Laura Zitella, Gerardo Colon-Otero, Daniel Petrylak, David Gandara
Modern Clinical Trial Design, Pharmacology and Drug Development
By: Mark Krailo (USC), Jon Beumer (UPMC), Harpreet Singh, MD (FDA)
Immunotherapy for GYO Malignancies: Is There Still Time for Progress?
By: Mark Shahin, MD, FACOG, FACS
Immunotherapy for GYO Malignancies: Is There Still Time for Progress?
By: Mark Shahin, MD, FACOG, FACS
